Meilani H Mapa, MD | |
3702 Washington St Ste 303, Hollywood, FL 33021 | |
(954) 518-2424 | |
(954) 981-3476 |
Full Name | Meilani H Mapa |
---|---|
Gender | Female |
Speciality | Physical Medicine And Rehabilitation |
Experience | 21 Years |
Location | 3702 Washington St Ste 303, Hollywood, Florida |
Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063600872 | NPI | - | NPPES |
014529200 | Medicaid | FL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | ME122717 (Florida) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Broward Health Medical Center | Fort lauderdale, FL | Hospital |
Entity Name | South Broward Hospital District |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1750726378 PECOS PAC ID: 8123927373 Enrollment ID: O20131126001497 |
News Archive
Ardea Biosciences, Inc. announced that it has completed formal End-of-Phase 2 meetings with the U.S. Food and Drug Administration (FDA) and successfully reached agreement on the following key aspects of its proposed lesinurad Phase 3 development plan: the overall size and design of the planned Phase 3 clinical studies, the primary endpoints, the total safety database proposed for NDA filing, manufacturing plans for both drug substance and drug product, the preclinical toxicology program and the clinical pharmacology program.
Researchers at the University of Colorado College of Nursing and the School of Medicine Department of Anesthesiology at the Anschutz Medical Campus found that the use of nitrous oxide as a pain relief option for individuals in labor is safe for newborn children and laboring individual, and converting to a different form of pain relief such as an epidural or opioid is influenced by a woman's prior birth history and other factors.
Active management of the third stage of labour means that women lose less blood than with a more expectant approach, reveals a thesis from the University of Gothenburg, Sweden, in conjunction with Sahlgrenska University Hospital.
The American Legacy Foundation's national truth youth smoking prevention campaign; accelerated the decline in youth smoking rates between 2000 and 2002.
The latest research to combat emerging infectious diseases threatening Australia is being presented at the Sydney Institute of Emerging Infectious Diseases and Biosecurity Conference at the University of Sydney today.
› Verified 5 days ago
Entity Name | University Of Miami |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1013967827 PECOS PAC ID: 3274795109 Enrollment ID: O20200406001006 |
News Archive
Ardea Biosciences, Inc. announced that it has completed formal End-of-Phase 2 meetings with the U.S. Food and Drug Administration (FDA) and successfully reached agreement on the following key aspects of its proposed lesinurad Phase 3 development plan: the overall size and design of the planned Phase 3 clinical studies, the primary endpoints, the total safety database proposed for NDA filing, manufacturing plans for both drug substance and drug product, the preclinical toxicology program and the clinical pharmacology program.
Researchers at the University of Colorado College of Nursing and the School of Medicine Department of Anesthesiology at the Anschutz Medical Campus found that the use of nitrous oxide as a pain relief option for individuals in labor is safe for newborn children and laboring individual, and converting to a different form of pain relief such as an epidural or opioid is influenced by a woman's prior birth history and other factors.
Active management of the third stage of labour means that women lose less blood than with a more expectant approach, reveals a thesis from the University of Gothenburg, Sweden, in conjunction with Sahlgrenska University Hospital.
The American Legacy Foundation's national truth youth smoking prevention campaign; accelerated the decline in youth smoking rates between 2000 and 2002.
The latest research to combat emerging infectious diseases threatening Australia is being presented at the Sydney Institute of Emerging Infectious Diseases and Biosecurity Conference at the University of Sydney today.
› Verified 5 days ago
Entity Name | San Lorenzo Pm & R Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1134894579 PECOS PAC ID: 9537565940 Enrollment ID: O20210910001064 |
News Archive
Ardea Biosciences, Inc. announced that it has completed formal End-of-Phase 2 meetings with the U.S. Food and Drug Administration (FDA) and successfully reached agreement on the following key aspects of its proposed lesinurad Phase 3 development plan: the overall size and design of the planned Phase 3 clinical studies, the primary endpoints, the total safety database proposed for NDA filing, manufacturing plans for both drug substance and drug product, the preclinical toxicology program and the clinical pharmacology program.
Researchers at the University of Colorado College of Nursing and the School of Medicine Department of Anesthesiology at the Anschutz Medical Campus found that the use of nitrous oxide as a pain relief option for individuals in labor is safe for newborn children and laboring individual, and converting to a different form of pain relief such as an epidural or opioid is influenced by a woman's prior birth history and other factors.
Active management of the third stage of labour means that women lose less blood than with a more expectant approach, reveals a thesis from the University of Gothenburg, Sweden, in conjunction with Sahlgrenska University Hospital.
The American Legacy Foundation's national truth youth smoking prevention campaign; accelerated the decline in youth smoking rates between 2000 and 2002.
The latest research to combat emerging infectious diseases threatening Australia is being presented at the Sydney Institute of Emerging Infectious Diseases and Biosecurity Conference at the University of Sydney today.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Meilani H Mapa, MD 2900 Corporate Way, Door D, Miramar, FL 33025-3925 Ph: (954) 276-5685 | Meilani H Mapa, MD 3702 Washington St Ste 303, Hollywood, FL 33021 Ph: (954) 518-2424 |
News Archive
Ardea Biosciences, Inc. announced that it has completed formal End-of-Phase 2 meetings with the U.S. Food and Drug Administration (FDA) and successfully reached agreement on the following key aspects of its proposed lesinurad Phase 3 development plan: the overall size and design of the planned Phase 3 clinical studies, the primary endpoints, the total safety database proposed for NDA filing, manufacturing plans for both drug substance and drug product, the preclinical toxicology program and the clinical pharmacology program.
Researchers at the University of Colorado College of Nursing and the School of Medicine Department of Anesthesiology at the Anschutz Medical Campus found that the use of nitrous oxide as a pain relief option for individuals in labor is safe for newborn children and laboring individual, and converting to a different form of pain relief such as an epidural or opioid is influenced by a woman's prior birth history and other factors.
Active management of the third stage of labour means that women lose less blood than with a more expectant approach, reveals a thesis from the University of Gothenburg, Sweden, in conjunction with Sahlgrenska University Hospital.
The American Legacy Foundation's national truth youth smoking prevention campaign; accelerated the decline in youth smoking rates between 2000 and 2002.
The latest research to combat emerging infectious diseases threatening Australia is being presented at the Sydney Institute of Emerging Infectious Diseases and Biosecurity Conference at the University of Sydney today.
› Verified 5 days ago
Virmarie Quinones-pagan, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 4651 Sheridan St Ste 150, Hollywood, FL 33021 Phone: 954-276-1600 Fax: 954-893-6244 | |
Breonna Elizabeth Holland, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 3702 Washington St Ste 303, Hollywood, FL 33021 Phone: 954-518-2424 Fax: 954-981-3476 | |
Robert Klecz, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3702 Washington St Ste 303, Hollywood, FL 33021 Phone: 954-518-2424 Fax: 954-981-3476 | |
Joanne M Delgado Lebron, M.D Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3702 Washington St Ste 303, Hollywood, FL 33021 Phone: 954-518-2424 Fax: 954-981-3476 | |
Galit Levy, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 4440 Sheridan St, Hollywood, FL 33021 Phone: 954-966-5156 Fax: 954-966-5909 | |
Dr. Dennis A Hart, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 4651 Sheridan St Ste 150, Hollywood, FL 33021 Phone: 954-276-1600 Fax: 954-893-6244 |